Home » Topics » Regulatory

Regulatory
RSS

European Commission approves Trisenox for first-line treatment of low to intermediate risk APL

Nov. 21, 2016

FDA approves Intrarosa to treat dyspareunia in postmenopausal women

Nov. 18, 2016

European approval for Parsabiv to treat secondary hyperparathyroidism in hemodialysis patients

Nov. 14, 2016

FDA approves Vemlidy to treat chronic HBV infection

Nov. 11, 2016

FDA approves Opdivo for head and neck cancer

Nov. 11, 2016

FDA approves Enbrel to treat children with moderate to severe plaque psoriasis

Nov. 7, 2016

Silvergate announces U.S. availability of Qbrelis

Oct. 27, 2016

FDA issues new approvals in NSCLC for Keytruda

Oct. 25, 2016

FDA approves Zinplava to reduce recurrence of C. difficile infection

Oct. 24, 2016

FDA grants accelerated approval for Lartruvo in soft tissue sarcoma

Oct. 20, 2016